We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+1.35%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$291M
AUM Growth
+$56.2M
(+24%)
Cap. Flow
+$59.8M
Cap. Flow
% of AUM
20.53%
Top 10 Holdings %
Top 10 Hldgs %
10.15%
Holding
767
New
242
Increased
169
Reduced
119
Closed
232
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$3.21M |
| 2 |
Visa
V
|
+$3.15M |
| 3 |
Cognizant
CTSH
|
+$3.12M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$3.06M |
| 5 |
Voya Financial
VOYA
|
+$2.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.36M |
| 2 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$2.35M |
| 3 |
CNL
CLECO CRP (HOLDING CO)
CNL
|
+$2.32M |
| 4 |
AET
Aetna Inc
AET
|
+$2.28M |
| 5 |
Keurig Dr Pepper
KDP
|
+$2.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.58% |
| 2 | Financials | 15.09% |
| 3 | Industrials | 12.15% |
| 4 | Healthcare | 11.73% |
| 5 | Consumer Discretionary | 11.32% |
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q2 2016 Portfolio in Review
As of Q2 2016, Seven Eight Capital held 767 positions worth $291M, up 24% from $235M the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Seven Eight Capital deployed $59.8M of net new capital in Q2 2016, opening 242 new positions and adding to 169 existing holdings. Its largest new stake was Mastercard: 33,600 shares worth $2.96M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Keurig Dr Pepper, an estimated $2.15M trimmed.
- Seven Eight Capital's largest Q2 2016 buy was Mastercard: 33,600 shares worth $2.96M.
- Seven Eight Capital added most to Voya Financial in Q2 2016, an estimated $2.9M increase.
- Seven Eight Capital's biggest Q2 2016 reduction was Keurig Dr Pepper, cutting an estimated $2.15M.
- Seven Eight Capital fully exited Allergan plc in Q2 2016, selling an estimated $2.36M.
- Seven Eight Capital's ten largest holdings make up 10% of its $291M portfolio in Q2 2016.
- Seven Eight Capital opened 242 new positions and closed 232 in Q2 2016.
- Seven Eight Capital's portfolio value rose 24% quarter-over-quarter to $291M.
Based on Seven Eight Capital's 13F filing for Q2 2016, filed 12 Aug 2016.